-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
22 Dec 2025 12:30 GMT
… depositary shares, each representing 1/1000 of a share of XOMA … January 2, 2026. About XOMA Royalty Corporation
XOMA Royalty is a biotechnology … available.
Investor Contact
Juliane Snowden
XOMA Royalty Corporation
+1 646-438 …
-
XOMA Royalty Enters into Agreement to Acquire Generation Bio
15 Dec 2025 22:00 GMT
… NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA), the biotech … total number of outstanding shares and other customary … subsidiary of XOMA Royalty, and all remaining shares not … DECISION REGARDING TENDERING THEIR SHARES. The Offer to …
-
Why Is XOMA Royalty Stock Sinking Thursday?
11 Dec 2025 19:01 GMT
… 40% improvement.
Background on XOMA–Rezolute Partnership
In 2017, … license agreement with XOMA for RZ358 (formerly XOMA 358) for Congenital … study.
Price Action: Rezolute shares were down 88.48% at … to Benzinga Pro data. XOMA Royalty shares were down 23.46% …
-
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
05 Dec 2025 14:00 GMT
… NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty … all of Mural’s shares will cease trading on Nasdaq … promptly to cause such shares to be delisted from … Mural’s shares. Other potential risks to XOMA Royalty meeting …
-
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
21 Nov 2025 12:45 GMT
… NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) today announced … for payment of all Shares tendered in the subsequent … resulting in XOMA Royalty acquiring 100% of the shares in … , public trading of the Shares was suspended, and LAVA …
-
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
12 Nov 2025 12:30 GMT
… , repurchased approximately 108,510 shares of its common stock for … Preferred stocks. About XOMA Royalty Corporation
XOMA Royalty is a biotechnology …
17,932
11,645
XOMA ROYALTY CORPORATION
CONDENSED CONSOLIDATED BALANCE …
-
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
10 Nov 2025 21:09 GMT
… the proposed transaction with XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA). On August 4 … (or waived), including insufficient ordinary shares of LAVA being tendered in … ANY DECISION REGARDING TENDERING THEIR SHARES (INCLUDING THE TERMS AND CONDITIONS …
-
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
24 Oct 2025 20:25 GMT
… owned subsidiary of XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA Royalty”). As described … 58 percent of the shares outstanding and eligible to be … 61 percent of the shares outstanding and eligible to be … the proposal. The Mural shares voted in favour of and …
-
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty
17 Oct 2025 20:18 GMT
… 23 per CVR.
LAVA and XOMA Royalty also agreed to amend … related to the deal with XOMA Royalty on November 7, after … XOMA. XOMA first announced that it would acquire LAVA in August.
LAVA shares … While LVTX shares have gained 56% this year, XOMA stock has risen …
-
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
17 Oct 2025 15:45 GMT
… NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) and LAVA … in XOMA Royalty acquiring 100% of the shares in … ), including insufficient ordinary shares of LAVA being tendered … DECISION REGARDING TENDERING THEIR SHARES (INCLUDING THE TERMS …